eudragit-e has been researched along with Stomach Ulcer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kerdsakundee, N; Mahattanadul, S; Wiwattanapatapee, R | 1 |
| Date, AA; Khachane, P; Nagarsenker, MS | 1 |
2 other study(ies) available for eudragit-e and Stomach Ulcer
| Article | Year |
|---|---|
Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit® EPO solid dispersions for gastric ulcer treatment.
Topics: Animals; Anti-Ulcer Agents; Curcumin; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Gastric Absorption; Gastric Mucosa; Male; Polymethacrylic Acids; Powder Diffraction; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Stomach; Stomach Ulcer; Viscosity | 2015 |
Eudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administration.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Male; Meloxicam; Microscopy, Electron, Transmission; Nanocapsules; Nanotechnology; Particle Size; Polymethacrylic Acids; Rats; Rats, Sprague-Dawley; Solubility; Stomach Ulcer; Thiazines; Thiazoles | 2011 |